Commercial boost for #AgeX and #pluripotent stem cells AgeX Therapeutics and Pluristyx Inc announce manufacturing, marketing and distribution agreement. #longevity #stemcells #hESCs #Pluristyx bit.ly/2YECOvI

AgeX Therapeutics Reports Third Quarter 2021 Financial Results: investors.agexinc.com/news/news-deta…

AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001 investors.agexinc.com/news/news-deta…

investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results investors.agexinc.com/news/news-deta…

AgeX is hiring a senior accountant: agexinc.com/careers/

AgeX Therapeutics Reports First Quarter 2022 Financial Results investors.agexinc.com/news/news-deta…

Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Second Quarter 2022 Financial Results investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Third Quarter 2022 Financial Results 11/10/2022 investors.agexinc.com/news/news-deta…

AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports First Quarter 2023 Financial Results investors.agexinc.com/news/news-deta…

AgeX Therapeutics Announces Appeal of NYSE American Determination investors.agexinc.com/news/news-deta…

AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock investors.agexinc.com/news/news-deta…

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Second Quarter 2023 Financial Results investors.agexinc.com/news/news-deta…

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement 08/30/2023 investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Third Quarter 2023 Financial Results investors.agexinc.com/news/news-deta…

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results investors.agexinc.com/news/news-deta…